Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hsu

Showing results (341-350 of 361) with videos related to

Pageof 37
Sort By:
Journal of Medicinal Chemistry|April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activitiesI-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Bioorganic Chemistry|March 16, 2020
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitorsShu-Yu Lin, Chun-Feng Chang, Mohane Selvaraj Coumar, et al.
Nature Neuroscience|March 27, 2012
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencingLinda Madisen, Tianyi Mao, Henner Koch, et al.
Journal of Medicinal Chemistry|February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studiesNeeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
European Journal of Medicinal Chemistry|June 18, 2015
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutationsChiung-Tong Chen, John T-A Hsu, Wen-Hsing Lin, et al.
Journal of Medicinal Chemistry|March 24, 2009
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonistsChia-Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar, et al.
Bioorganic & Medicinal Chemistry|June 29, 2011
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, Shu-Yi Hsieh, Shih-Chieh Yen, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Pageof 37

Showing results (341-350 of 361) with videos related to

Sort By:
Pageof 37
Journal of Medicinal Chemistry|April 28, 2006
Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activitiesI-Lin Lu, Chien-Fu Huang, Yi-Hui Peng, et al.
Pediatrics|March 14, 1998
A phase I/II study of the protease inhibitor ritonavir in children with human immunodeficiency virus infectionB U Mueller, R P Nelson, J Sleasman, et al.
Bioorganic Chemistry|March 16, 2020
Drug-like property optimization: Discovery of orally bioavailable quinazoline-based multi-targeted kinase inhibitorsShu-Yu Lin, Chun-Feng Chang, Mohane Selvaraj Coumar, et al.
Nature Neuroscience|March 27, 2012
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencingLinda Madisen, Tianyi Mao, Henner Koch, et al.
Journal of Medicinal Chemistry|February 3, 2006
Indol-1-yl acetic acids as peroxisome proliferator-activated receptor agonists: design, synthesis, structural biology, and molecular docking studiesNeeraj Mahindroo, Chiung-Chiu Wang, Chun-Chen Liao, et al.
Analytical Biochemistry|March 25, 2008
A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitorsWen-Hsing Lin, Jen-Shin Song, Teng-Yuan Chang, et al.
European Journal of Medicinal Chemistry|June 18, 2015
Identification of a potent 5-phenyl-thiazol-2-ylamine-based inhibitor of FLT3 with activity against drug resistance-conferring point mutationsChiung-Tong Chen, John T-A Hsu, Wen-Hsing Lin, et al.
Journal of Medicinal Chemistry|March 24, 2009
Design and structural analysis of novel pharmacophores for potent and selective peroxisome proliferator-activated receptor gamma agonistsChia-Hui Lin, Yi-Hui Peng, Mohane Selvaraj Coumar, et al.
Bioorganic & Medicinal Chemistry|June 29, 2011
Discovery and evaluation of 3-phenyl-1H-5-pyrazolylamine-based derivatives as potent, selective and efficacious inhibitors of FMS-like tyrosine kinase-3 (FLT3)Wen-Hsing Lin, Shu-Yi Hsieh, Shih-Chieh Yen, et al.
Journal of Medicinal Chemistry|July 2, 2013
Optimization of ligand and lipophilic efficiency to identify an in vivo active furano-pyrimidine Aurora kinase inhibitorHui-Yi Shiao, Mohane Selvaraj Coumar, Chun-Wei Chang, et al.
Pageof 37